TRIMBOW Drug Patent Profile
✉ Email this page to a colleague
When do Trimbow patents expire, and when can generic versions of Trimbow launch?
Trimbow is a drug marketed by Chiesi and is included in one NDA.
The generic ingredient in TRIMBOW is beclomethasone dipropionate; formoterol fumarate; glycopyrrolate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate; formoterol fumarate; glycopyrrolate profile page.
US Patents and Regulatory Information for TRIMBOW
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | TRIMBOW | beclomethasone dipropionate; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 219622-001 | May 14, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chiesi | TRIMBOW | beclomethasone dipropionate; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 219622-002 | May 14, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
